• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Polomar Health Services, Inc. (TRFE)
	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014	Q4-CY2013
Balance Sheet Date		2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31
Fiscal Period		Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024	Q1-FY2024	Q4-FY2023
Total Revenue		6,163$	5,470$	4,542$	20,870$	9,849$	14,495$	13,610$	17,288$	21,457$
QoQ%		12.67%	20.43%	(78.24%)	111.90%	(32.05%)	6.50%	(21.28%)	(19.43%)
YoY%		(37.43%)	(62.26%)	(66.63%)	20.72%	(54.10%)
Cost Of Revenue		1,840$	1,638$	1,360$	11,800$	985$	4,239$	10,897$	2,224$	1,534$
Gross Profit		4,323$	3,832$	3,182$	9,070$	8,864$	10,256$	2,713$	15,064$	19,923$
Gross Margin		70.14%	70.06%	70.06%	43.46%	90.00%	70.76%	19.93%	87.14%	92.85%
Operating Expenses		633,131$	567,165$	418,590$	698,182$	268,037$	200,998$	163,181$	109,601$	154,601$	90,958$	89,806$
Operating Income		(628,808$)	(563,333$)	(415,408$)	(689,112$)	(259,173$)	(190,742$)	(160,468$)	(94,537$)	(134,678$)	(90,958$)	(89,806$)
Operating Margin		(10,202.95%)	(10,298.59%)	(9,145.93%)	(3,301.93%)	(2,631.47%)	(1,315.92%)	(1,179.05%)	(546.84%)	(627.67%)
Interest Income
Interest Expenses
Income Before Tax		(649,775$)	(605,563$)	(456,855$)	(718,790$)	(271,333$)	(190,742$)	(160,468$)	(127,594$)	(172,163$)	(90,958$)	(89,806$)
Tax Expenses
Net Income		(649,775$)	(605,563$)	(456,855$)	(718,790$)	(271,333$)	(190,742$)	(160,468$)	(127,594$)	(172,163$)	(90,958$)	(89,806$)
Profit Margin		(10,543.16%)	(11,070.62%)	(10,058.45%)	(3,444.13%)	(2,754.93%)	(1,315.92%)	(1,179.05%)	(738.05%)	(802.36%)
TTM		(6,562.24%)	(5,039.26%)	(3,291.50%)	(2,280.25%)	(1,357.91%)	(973.77%)
Earnings to Minority
Earnings to Common Shareholders		(649,775$)	(605,563$)	(456,855$)	(718,790$)	(271,333$)	(190,742$)	(160,468$)	(127,594$)	(172,163$)	(90,958$)	(89,806$)
QoQ%		(7.30%)	(32.55%)	36.44%	(164.91%)	(42.25%)	(18.87%)	(25.77%)	25.89%	(89.28%)	(1.28%)
YoY%		(139.48%)	(217.48%)	(184.70%)	(463.34%)	(57.60%)	(109.70%)	(78.68%)
Earnings Per Share, Basic		(0.02$)	(0.02$)	(0.02$)	(0.03$)	(0.01$)	(0.01$)	(0.01$)	0.00$	(0.01$)	0.00$	0.00$
Earnings Per Share, Diluted
Unlevered FCF Per Share, Basic		(0.01$)	(0.01$)	0.00$	(0.01$)	(0.02$)	(0.01$)	(0.01$)	0.00$	(0.01$)	0.00$	0.00$
Unlevered FCF Per Share, Diluted
Average Shares, Basic		28,008,183	27,667,155	27,657,679	27,657,696	27,655,560	27,655,560	27,655,560	-140,286,782	27,655,560	108,564,879	108,517,979
Average Shares, Diluted
EBIT		(649,775$)	(605,563$)	(456,855$)	(718,790$)	(271,333$)	(190,742$)	(160,468$)	(127,594$)	(172,163$)	(90,958$)	(89,806$)
EBITDA		(390,663$)	(346,450$)	(197,742$)	(462,840$)	(271,333$)	(189,074$)	(157,969$)	(127,594$)	(172,163$)	(90,958$)	(89,806$)

Copy Table ✓